Clinical Trial Update: A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

View source ↗

Summary

Clinical trial update indicates Janssen’s study on acute respiratory viral infections in high-risk participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Respiratory Viral Infection | Status: COMPLETED